Subscribe to our Telegram channel for the latest stories and updates.
A group made up of pharmaceutical and medical supply experts in Thailand is working to produce a nasal spray that can prevent covid-19.
The Star reported that the nasal spray works by helping the body produce antibodies that can fight the Covid-19 virus.
If the nasal spray works, hopefully it will be one of the drugs that the Ministry of Health (KKM) will consider and approve for use here.
According to the New Straits Times, the Bangkok Post reported that experts from Chulalongkorn University, Silpakom University, the Health Systems Research Institute (HSRI), the Government Pharmaceutical Organization (GPO), and Siam Bioscience worked together on the project.
The joint venture to develop the spray aims to boost Thai innovation and research efforts to meet international standards.
Reports indicate that the nasal spray will be available for sale to the public in the third quarter, possibly around September of this year.
GPO deputy director Rangsee Patlee said the group had been granted a certificate by the Food and Drug Administration (FDA) to produce respiratory care medical supplies that enable the distribution of the nasal spray solution developed by GPO.
The anti-Covid-19 nasal spray is also certified by the International Organization for Standardization (ISO) for medical devices.
As our facilities have passed the ISO requirements for the distribution of medical supplies, we can guarantee that the production of this anti-Covid-19 product is safe and of good quality.
GPO Deputy Director, Rangsee Patlee
Thailand has also produced its own vaccines against Covid-19
New Straits Times reported that GPO is also known for producing Thailand’s second Covid-19 vaccine, HXP-GPOVac, which had gone through its first and second clinical trials.
Laboratory results showed that the vaccine can prevent the Omicron variant, and the FDA is considering its approval. The third trial and distribution of the vaccine could start in mid-2023.
In addition, the mRNA vaccine developed by the Chula Vaccine Research Center at Chulalongkorn University and King Chulalongkorn Memorial Hospital in Bangkok has shown efficiency that matches Pfizer and Moderna’s vaccines, The Star reported.
The vaccine will undergo its third clinical trial and will be ready for public use once it is approved by the FDA.
Malaysia is studying other vaccination methods
In March 2022, The Malay Mail reported that the Malaysian government is looking into other methods of administering vaccines, such as oral medications or nasal sprays.
Deputy Minister of Science, Technology and Innovation Datuk Ahmad Amzad Hashim said that different methods of administering vaccines were being studied because they are people who are afraid of needles that may deter them from taking the covid-19 vaccines.
The Covid-19 pandemic has led to unscrupulous people and companies selling questionable cures.
Most of these supposed Covid-19 cures take advantage of people’s desperation and are based on the placebo effect.
To be safe, it’s best to check with your doctor before taking any miracle drug.
READ MORE: Mobile phone retailer fined RM10,000 for selling unregistered anti-covid-19 drugs in Sabah
READ MORE: Aunt hospitalized after taking ivermectin, convinced mRNA vaccines are against her religion
READ MORE: Malaysian clinical study on the ineffectiveness of ivermectin is published in a medical journal
Share your thoughts with us through TRP Facebook, Twitterand Instagram.